Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Nausea × alizapride × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Vomiting 1 Neoplasms 1 Nausea 1 Breast Neoplasms 1

Interventions

Dexamethasone 33 Aprepitant 30 Ondansetron 25 Palonosetron 22 Granisetron 16 Calcium Dobesilate 15 Olanzapine 12 Therapeutics 8 dexamethasone acetate 7 Cyclophosphamide 7 fosaprepitant 6 casopitant 6 Doxorubicin 6 Radiotherapy 5 netupitant 4 dolasetron 4 dexamethasone 21-phosphate 4 Vincristine 4 Tropisetron 4 Metoclopramide 4 Acupressure 4 Prochlorperazine 3 Lorazepam 3 Electroacupuncture 3 Dronabinol 3 Cisplatin 3 peppermint oil 2 netupitant, palosentron drug combination 2 ginger extract 2 auricularum 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01636947 2018-09-25

KMEC

Merck Sharp & Dohme LLC

Phase 4 Completed

494 enrolled 14 charts

Nausea, Neoplasms, Vomiting

Data powered by HemOnc (CC BY 4.0) Colophon ⚡